Paul W Nutter
Overview
Explore the profile of Paul W Nutter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lubasinski N, Thabit H, Nutter P, Harper S
Nutrients
. 2024 Jul;
16(14.
PMID: 39064657
Introduction: Type 1 Diabetes (T1D) affects over 9 million worldwide and necessitates meticulous self-management for blood glucose (BG) control. Utilizing BG prediction technology allows for increased BG control and a...
2.
Lubasinski N, Thabit H, Nutter P, Harper S
Nutrients
. 2024 Jun;
16(11).
PMID: 38892623
Introduction: Type 1 Diabetes (T1D) presents self-management challenges, requiring an additional 180 daily decisions to regulate blood glucose (BG) levels. Despite the potential, T1D-focused applications have a 43% attrition rate....
3.
Worth C, Nutter P, Salomon-Estebanez M, Auckburally S, Dunne M, Banerjee I, et al.
Digit Health
. 2023 Aug;
9:20552076231192011.
PMID: 37545627
Background: Children with hypoglycaemia disorders, such as congenital hyperinsulinism (CHI), are at constant risk of hypoglycaemia (low blood sugars) with the attendant risk of brain injury. Current approaches to hypoglycaemia...
4.
Worth C, Hoskyns L, Salomon-Estebanez M, Nutter P, Harper S, Derks T, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
14:1116864.
PMID: 36755920
In 2023, childhood hypoglycaemia remains a major public health problem and significant risk factor for consequent adverse neurodevelopment. Irrespective of the underlying cause, key elements of clinical management include the...
5.
Worth C, Dunne M, Salomon-Estebanez M, Harper S, Nutter P, Dastamani A, et al.
Front Endocrinol (Lausanne)
. 2022 Nov;
13:1016072.
PMID: 36407313
Objective: Continuous Glucose Monitoring (CGM) is gaining in popularity for patients with paediatric hypoglycaemia disorders such as Congenital Hyperinsulinism (CHI), but no standard measures of accuracy or associated clinical risk...
6.
Worth C, Nutter P, Dunne M, Salomon-Estebanez M, Banerjee I, Harper S
Digit Health
. 2022 Oct;
8:20552076221129712.
PMID: 36276186
Background: Children with congenital hyperinsulinism (CHI) are at constant risk of hypoglycaemia with the attendant risk of brain injury. Current hypoglycaemia prevention methods centre on the prediction of a continuous...
7.
Auckburally S, Worth C, Salomon-Estebanez M, Nicholson J, Harper S, Nutter P, et al.
Front Endocrinol (Lausanne)
. 2022 Aug;
13:894559.
PMID: 35928891
Background And Aims: In patients with congenital hyperinsulinism (CHI), recurrent hypoglycaemia can lead to longstanding neurological impairments. At present, glycaemic monitoring is with intermittent fingerprick blood glucose testing but this...
8.
Worth C, Harper S, Salomon-Estebanez M, OShea E, Nutter P, Dunne M, et al.
J Med Internet Res
. 2021 Aug;
23(10):e26957.
PMID: 34435596
Background: Hyperinsulinism (HI) due to excess and dysregulated insulin secretion is the most common cause of severe and recurrent hypoglycemia in childhood. High cerebral glucose use in the early hours...